Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1600 1632 1657
This examiner grants 70% of resolved cases
Kara D. Johnson is an examiner in Art Unit 1600 within Tech Center 1600. She has 505 resolved cases and an allowance rate of 69.5 percent. This suggests a generally positive environment for applicants, with a majority of cases reaching allowance. The examiner's experience with 505 cases indicates a well-established and predictable approach to the examination process.
The interview lift is 24.6 percent. This is a significant positive lift, indicating that interviews are a very effective tool for increasing the 69.5 percent baseline allowance rate. Direct communication is highly recommended to resolve technical issues and clarify claim language. Practitioners should use the 24.6 percent lift to their advantage to secure a grant more reliably.
The median days to allowance is 1135. This is a moderate pendency, representing a reasonable timeline for successful prosecution. Given the 24.6 percent lift, practitioners should use interviews to improve the 69.5 percent odds of success and manage the 1135 day timeline. This proactive strategy can help move applications through the process more efficiently and address the examiner's specific concerns.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 17996943 | METHOD FOR PRODUCING MILK LIKE PRODUCTS | Non-Final OA | SOCIETE DES PRODUITS NESTLE S.A. |
| 18742930 | SC-BETA CELLS AND COMPOSITIONS AND METHODS FOR GENERATING THE SAME | Non-Final OA | President and Fellows of Harvard College |
| 18672600 | METHODS AND COMPOSITIONS FOR THE PRODUCTION OF OLIGODENDROCYTE PROGENITOR CELLS | Non-Final OA | President and Fellows of Harvard College |
| 17693457 | Methods And Compositions For Aesthetic And Cosmetic Treatment And Stimulating Hair Growth | Non-Final OA | Pluri Biotech Ltd. |
| 17045459 | 3D SPATIALLY PATTERNED LYMPH NODE ON A MICROFLUIDIC DEVICE | Non-Final OA | University of Virginia Patent Foundation |
| 18167467 | Improved Cortical Spheroids and Methods of Making the Same | Final Rejection | The Florida State University Research Foundation, Inc. |
| 18819281 | TISSUE MATRIX MATERIALS AND ENZYMATIC ADHESIVES | Non-Final OA | LifeCell Corporation |
| 18661510 | TIL EXPANSION PROCESSES USING SPECIFIC CYTOKINE COMBINATIONS AND/OR AKTI TREATMENT | Non-Final OA | Iovance Biotherapeutics, Inc. |
| 17859466 | METHOD FOR PRODUCING FUSION PROTEIN HAVING IGG FC DOMAIN | Final Rejection | ALTEOGEN, INC. |
| 18697799 | CELL CULTURE PLATFORMS, METHODS AND USES THEREOF | Non-Final OA | ACADEMIA SINICA |
| 18262441 | APPLICATION OF PERMITTIVITY MEASUREMENT PROBES IN AN SUSPENSION CULTURE AGGREGATE COMPRISING CELL AGGREGATES | Non-Final OA | REPAIRON GMBH |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy